Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
about
Probiotics as adjunctive therapy for eradication of Helicobacter pylori infectionLactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.Systematic review and meta-analysis of Saccharomyces boulardii in adult patientsVaccine against Helicobacter pylori: Inevitable approachMicrobiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell TransplantationAre probiotics useful in Helicobacter pylori eradication?Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agentSystematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events.'Rescue' therapies for the management of Helicobacter pylori infection.Treatment of Helicobacter pylori infection: current status and future concepts.The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trialDo probiotics have a therapeutic role in gastroenterology?Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis.Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal culturesFighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study.Improving compliance with helicobacter pylori eradication therapy: when and how?Second-line rescue therapy of helicobacter pylori infection.The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysisSystematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.Clinical indications for probiotics: an overview.Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.Role of probiotics in patients with Helicobacter pylori infection.Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis.Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pyloriProbiotics, prebiotics and the gastrointestinal tract in health and disease.Review article: the treatment of refractory Helicobacter pylori infection.Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysisProbiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis.Improved Helicobacter pylori Eradication Rate of Tailored Triple Therapy by Adding Lactobacillus delbrueckii and Streptococcus thermophilus in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial.Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults.Effectiveness of probiotic in preventing and treating antibiotic-associated diarrhoea and/or Clostridium difficile-associated diarrhoea in patients with spinal cord injury: a protocol of systematic review of randomised controlled trialsPotential protective effects of Clostridium butyricum on experimental gastric ulcers in miceAntagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.Probiotics and gastrointestinal diseases.Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy.
P2860
Q24197882-5A10E00A-9232-42D7-AE1D-72F4A64C605EQ24535026-C37EE5BA-CC4B-4DD9-828E-F55F91794E74Q24621081-7D93A2A4-46F9-47BA-8E38-6EC1F775A75BQ26752743-119F79E5-2D86-40DF-9141-AD966D0C3773Q26771287-1B3339B7-296F-472C-B62B-FF45F102C48AQ26784386-4E8D3F8C-F0B2-4A4E-AE41-6ACAE5E8541FQ26991504-596E90DA-9785-4F85-A0CD-CAADF859A161Q27322371-45935A04-75A8-470B-A692-5E20EE22BA98Q33371187-23C6404B-4BB2-414E-AA14-3AE283826F8EQ33594850-0A706888-2CFD-4AE2-82E0-DEF7E5B22ED3Q33596735-D3255D43-184D-4BC2-A485-4DE7F1EB0B20Q33869477-83823AB2-AC1F-49E8-9EAE-FECFD3C14FB4Q34094620-63CD1E82-A3E9-4080-873C-E3F40564908EQ34097784-D59B1D31-C6A5-4880-89EA-ABA4CF04E6BEQ34286137-0A5AA783-B749-4B02-9F46-47FB3EF10FCFQ34369059-07061486-AD2D-48A2-AB4C-5346D6B33D57Q34409052-373A3EAD-1891-46F8-AF06-4F36F58121DFQ34409114-D4074F1D-5E56-4FC1-A679-D7C763E22572Q34443924-DE5ED55C-91BF-44D6-9119-7562CF7E385FQ34487166-1DEC5ACF-72F2-4751-A071-C308C1477731Q34517039-84B2E0FC-56E1-4B1A-B495-50F03835923FQ34566465-35887DFC-B894-4FC3-B73B-86CA45EF5ECEQ34572969-1E5845B6-B3DE-4393-8F54-C55B77CA3275Q34586857-BE97CAD3-69F0-40F6-863D-9FE6CED8F4B8Q34622749-9F6AD678-098A-462C-AA53-62D621D8F437Q34636521-52C9C5B5-2E2E-412F-A874-0074B4B9598BQ34711908-425576AC-B481-468E-AC7A-D80AEC2C66F0Q35048716-4CD9CFE9-06FA-4DCA-9C13-BD28D8A0B040Q35104855-9A66A7D4-A52C-45CF-A64E-F9857DB08C76Q35122167-CF635168-74D1-4411-AAB8-F1553B9BD7B0Q35145092-188B5E09-8145-464F-9911-537A6815E780Q35375748-C6AD743A-C951-449A-85AA-690D5175F233Q35692273-4F7034F4-2DDA-43B5-B3C4-0BBD6D5891F0Q35763686-BD3B41A9-42CC-45F1-99BD-EF6219536CAEQ35771988-96A84D9E-BE83-41AC-B780-50EF6B0F860DQ35848822-CEF61E2A-0FC8-493D-BE99-32DEE09E05D6Q35865246-9602C262-2522-47D6-A278-C3F5608F3B00Q35890738-92959D5A-E350-4F46-8050-AE25A09E956CQ35987864-BAE1A837-6196-4014-BCE4-6A9D99A8A54EQ36011539-6A635656-0AF9-40CA-A357-949F5DB849F1
P2860
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of different probiotic ...... ind, placebo-controlled study.
@ast
Effect of different probiotic ...... ind, placebo-controlled study.
@en
type
label
Effect of different probiotic ...... ind, placebo-controlled study.
@ast
Effect of different probiotic ...... ind, placebo-controlled study.
@en
prefLabel
Effect of different probiotic ...... ind, placebo-controlled study.
@ast
Effect of different probiotic ...... ind, placebo-controlled study.
@en
P2093
P2860
P921
P1476
Effect of different probiotic ...... ind, placebo-controlled study.
@en
P2093
Alessandro Armuzzi
Antonio Gasbarrini
Enrico C Nista
Filippo Cremonini
Giovanni Cammarota
Luca Santarelli
Marcello Covino
Simona Di Caro
P2860
P304
P356
10.1111/J.1572-0241.2002.07063.X
P407
P577
2002-11-01T00:00:00Z